Altium Capital Management LLC / PHAT
Altium Capital Management LLC’s Phathom Pharmaceuticals Inc Position
Does Altium Capital Management LLC own Phathom Pharmaceuticals Inc (PHAT)? Not currently — the last reported position was 220.0K shares worth $2M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q3 2023
Shares
220.0K
% of Portfolio
+1.19%
Quarters Held
2
position exited
Position History PHAT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of PHAT.